We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
News & Events
Optimized Pathogen Detection : A Compatibility Evaluation of Revvity chemagic™360 system and NZYTechs MRSA and GBS qPCR detections Kits
Automated nucleic acid extraction systems have revolutionized the field of molecular diagnostics, enabling laboratories to generate reliable and high-quality results in a timely manner. One such system is the chemagic™ 360 instrument from Revvity, which provides a flexible and compact solution for automated DNA and RNA purification.
The chemagic™ Pathogen NA gDNA Kit H96 is a specialized kit designed for the isolation of DNA and RNA from bacteria and viruses, making it an ideal choice for the detection of microbial pathogens in clinical samples. Two common bacterial pathogens associated with healthcare-associated infections (HAIs) are Group B Streptococcus (GBS) and Methicillin-resistant Staphylococcus aureus (MRSA), and the early detection and accurate diagnosis of these pathogens is critical for effective treatment and prevention of HAIs.
NZYTech offers two Real-time PCR kits - the MRSA Multiplex Real-time PCR Kit, IVD, and the Group B Streptococcus Real-time PCR Kit, IVD - that provide rapid and precise identification of these bacteria. In this context, the compatibility of the chemagic system - chemagic™ 360 instrument plus chemagic™ Pathogen NA gDNA Kit H96 - with NZYTech's qPCR kits for MRSA and GBS detection is of utmost importance.
The combined use of the chemagic™ system and NZYTech's qPCR kits offers several advantages to molecular diagnostic laboratories. The chemagic™ system provides high yields of ultra-pure nucleic acids suitable for a wide range of downstream applications, while the NZYTech qPCR kits offer rapid and precise identification of bacterial pathogens.
Moreover, the compatibility of these two systems simplifies the workflow and reduces the risk of contamination, thereby increasing the efficiency and reliability of the entire process. This combined approach is particularly beneficial for laboratories that require high-throughput processing of clinical samples.
For this reason, the chemagic™ system from Revvity and NZYTech's qPCR kits for MRSA and GBS detection offer a powerful solution for automated nucleic acid extraction and rapid identification of bacterial pathogens in clinical samples. The compatibility of these systems ensures efficient and reliable results in a timely manner, making them an essential tool for molecular diagnostic laboratories and thus an endorsed solution to use in your workflow.
Would you like to know more?
Read our Endorsed Technical File